Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years

Andreas Blesl; Lukas Binder; Christoph Hoegenauer; H Wenzl; Andrea Borenich; Gudrun Pregartner; Andrea Berghold; S Mestel; Patrizia Constantini-Kump; Franziska Baumann-Durchschein; Wolfgang Petritsch

doi:10.1093/ecco-jcc/jjab076.548

Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Fachzeitschrift	Journal of Crohn's and Colitis
DOIs	https://doi.org/10.1093/ecco-jcc/jjab076.548
Publikationsstatus	Veröffentlicht - 2021
Veranstaltung	16th Congress of European Crohn's and Colitis Organisation 2021 - online Dauer: 8 Juli 2021 → 10 Juli 2021

Wissenschaftszweige

101 Mathematik
102 Informatik
301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin
305 Andere Humanmedizin, Gesundheitswissenschaften

Zugriff auf Dokument

10.1093/ecco-jcc/jjab076.548

Andere Dateien und Links

Web of Science

Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years
Blesl, A. (Autor*in), Binder, L. (Autor*in), Hoegenauer, C. (Autor*in), Wenzl, H. (Autor*in), Borenich, A. (Autor*in), Pregartner, G. (Autor*in), Berghold, A. (Autor*in), Mestel, S. (Autor*in), Constantini-Kump, P. (Autor*in), Baumann-Durchschein, F. (Autor*in) & Petritsch, W. (Autor*in)
2021
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

Blesl, A., Binder, L., Hoegenauer, C., Wenzl, H., Borenich, A., Pregartner, G., Berghold, A., Mestel, S., Constantini-Kump, P., Baumann-Durchschein, F., & Petritsch, W. (2021). Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjab076.548

@article{0fe7d2f6214044c3992902e52db95964,

title = "Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years",

author = "Andreas Blesl and Lukas Binder and Christoph Hoegenauer and H Wenzl and Andrea Borenich and Gudrun Pregartner and Andrea Berghold and S Mestel and Patrizia Constantini-Kump and Franziska Baumann-Durchschein and Wolfgang Petritsch",

year = "2021",

doi = "10.1093/ecco-jcc/jjab076.548",

language = "English",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

note = "16th Congress of ECCO {\textendash} Inflammatory Bowel Diseases, ECCO-IBD 2021 ; Conference date: 08-07-2021 Through 10-07-2021",

}

Blesl, A, Binder, L, Hoegenauer, C, Wenzl, H, Borenich, A , Pregartner, G , Berghold, A, Mestel, S, Constantini-Kump, P , Baumann-Durchschein, F & Petritsch, W 2021, 'Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years', Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjab076.548

TY - JOUR

T1 - Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years

AU - Blesl, Andreas

AU - Binder, Lukas

AU - Hoegenauer, Christoph

AU - Wenzl, H

AU - Borenich, Andrea

AU - Pregartner, Gudrun

AU - Berghold, Andrea

AU - Mestel, S

AU - Constantini-Kump, Patrizia

AU - Baumann-Durchschein, Franziska

AU - Petritsch, Wolfgang

PY - 2021

Y1 - 2021

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000709432400547

U2 - 10.1093/ecco-jcc/jjab076.548

DO - 10.1093/ecco-jcc/jjab076.548

M3 - Conference abstract

SN - 1873-9946

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

T2 - 16th Congress of ECCO – Inflammatory Bowel Diseases

Y2 - 8 July 2021 through 10 July 2021

ER -

Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years

Wissenschaftszweige

Zugriff auf Dokument

Andere Dateien und Links

Aktivitäten

Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years

Dieses zitieren